IMAX (IMAX) stock moved after Universal’s Disclosure Day delivered a robust opening weekend, with IMAX premium screens capturing nearly 15% of the film’s US$93.9 million global box office.

Beyond this weekend’s box office boost, IMAX’s recent share price momentum has been building, with a 30 day share price return of 33.97% and a 1 year total shareholder return of 51.82% reflecting how investors are reassessing both growth potential and risk.

If this kind of momentum has you thinking about what else could be on your radar, it may be worth scanning the market for other premium entertainment and media platforms using the 20 top founder-led companies

With IMAX stock up strongly over 1 year and trading only about 6% below one analyst price target and roughly 12% below one intrinsic value estimate, is there still a buying opportunity here, or is the market already pricing in future growth?

Most Popular Narrative: 5.3% Undervalued

Based on the most followed narrative, IMAX stock at a last close of $44.33 is compared with a fair value estimate of $46.82, setting up a modest valuation gap for investors to evaluate.

Diversification of content offerings, including local-language blockbusters, alternative content (concerts, live events), and deeper relationships with streaming and tech partners like Apple, Amazon, and Netflix, is broadening IMAX's audience base and improving margin mix, contributing to higher contribution per screen and more resilient earnings.

Curious what underpins that fair value for IMAX? The narrative leans heavily on faster top line expansion, much higher margins, and a richer earnings profile than current results imply.

Result: Fair Value of $46.82 (UNDERVALUED)

However, the IMAX story can be pressured if consumer attention continues shifting to at-home entertainment or if reliance on big tentpole releases leads to uneven box office results.

Another View on IMAX Stock: Earnings Multiple Sends a Different Signal

While the IMAX fair value narrative points to around 5.3% undervaluation, the earnings multiple tells a different story. IMAX trades on a P/E of 66.3x, compared with a fair ratio of 29.6x, a US Entertainment industry average of 24.8x, and a peer average of 56.4x, which suggests investors are paying a rich premium and taking on valuation risk if expectations cool.

For a closer look at what this gap could mean for IMAX and similar companies, including where the market P/E could migrate toward that fair ratio, See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With IMAX presenting both optimism and caution in this article, it makes sense to move quickly and review the details yourself. To weigh up the balance of these issues and decide where you stand, take a close look at the 3 key rewards and 1 important warning sign

Looking for more investment ideas beyond IMAX?

If IMAX has sharpened your focus on opportunities, do not stop here; use the Simply Wall St screener to line up your next potential moves with intent.

• Spot potential bargains early by scanning a curated set of screener containing 20 high quality undiscovered gems that may not yet be crowded with attention.
• Strengthen your portfolio’s foundations by checking companies in the solid balance sheet and fundamentals stocks screener (48 results) where financial resilience is a key filter.
• Target cash flow plus income by reviewing businesses in the 8 dividend fortresses that aim to pair yield with underlying fundamentals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.